Literature DB >> 9559741

Lattice corneal dystrophy type 1 in a Canadian kindred is associated with the Arg124 --> Cys mutation in the kerato-epithelin gene. sgupta@ogh.on.ca.

S K Gupta1, W G Hodge, K F Damji, D L Guernsey, P E Neumann.   

Abstract

PURPOSE: To identify the mutation responsible for lattice corneal dystrophy type 1 in an extended Canadian kindred.
METHODS: A search for a mutation in the candidate gene, kerato-epithelin, was carried out by single-strand conformation polymorphism and sequencing analyses.
RESULTS: AC --> T mutation at position 417 was detected in exon 4 of the kerato-epithelin gene, which is expected to cause an Arg124 --> Cys change. This is the same nucleotide change described previously in two Swiss families with lattice corneal dystrophy type 1.
CONCLUSION: Although the possibility that the three families (two previously described Swiss families and this Canadian kindred) are related has not been excluded, it appears that the unique phenotype of lattice corneal dystrophy type 1 is caused by this particular amino acid change.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559741     DOI: 10.1016/s0002-9394(99)80196-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  A clinical and molecular-genetic analysis of Chinese patients with lattice corneal dystrophy and novel Thr538Pro mutation in the TGFBI (BIGH3) gene.

Authors:  Ping Yu; Yangshun Gu; Yuehong Yang; Xiaoyi Yan; Lili Chen; Zhen Ge; Ming Qi; Jianmin Si; Lei Guo
Journal:  J Genet       Date:  2006-04       Impact factor: 1.166

2.  Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies.

Authors:  K Nishida; A J Quantock; A Dota; N H Choi-Miura; S Kinoshita
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

3.  Arg124Cys mutation of the TGFBI gene in a Chinese pedigree of Reis-Bücklers corneal dystrophy.

Authors:  Qiao-Na Yang; Yong-Wang Zhao; Li-Heng Guo; Nai-Hong Yan; Xu-Yang Liu; Su-Ping Cai
Journal:  Int J Ophthalmol       Date:  2011-06-18       Impact factor: 1.779

4.  Novel and known mutations of TGFBI, their genotype-phenotype correlation and structural modeling in 3 Chinese families with lattice corneal dystrophy.

Authors:  Xingwu Zhong; Suqin Chen; Weijun Huang; Jun Yang; Xiaolian Chen; Yan Zhou; Qiang Zhou; Yiming Wang
Journal:  Mol Vis       Date:  2010-02-15       Impact factor: 2.367

5.  Different phenotypes of lattice corneal dystrophy type I in patients with 417C>T (R124C) and 1762A>G (H572R) mutations in TGFBI (BIGH3).

Authors:  Pablo Romero; Mauricio Moraga; Luisa Herrera
Journal:  Mol Vis       Date:  2010-08-13       Impact factor: 2.367

6.  H626R and R124C mutations of the TGFBI (BIGH3) gene caused lattice corneal dystrophy in Vietnamese people.

Authors:  H M Chau; N T Ha; L X Cung; T K Thanh; K Fujiki; A Murakami; A Kanai
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

7.  Surgical outcome after phototherapeutic keratectomy in patients with TGFBI-linked corneal dystrophies in relation to molecular genetic findings.

Authors:  Claudia Gruenauer-Kloevekorn; Saskia Braeutigam; Ursula G Froster; Gernot I W Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-06       Impact factor: 3.117

8.  An Arg124Cys mutation in transforming growth factor β-induced gene associated with lattice corneal dystrophy type I in a Chinese pedigree.

Authors:  Feng Li; Jiahuan He; Hua Bai; Yifei Huang; Fang Wang; Lei Tian
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

9.  An R124C mutation in TGFBI caused lattice corneal dystrophy type I with a variable phenotype in three Chinese families.

Authors:  Zhe Liu; Yi-qiang Wang; Qing-hua Gong; Li-xin Xie
Journal:  Mol Vis       Date:  2008-06-30       Impact factor: 2.367

10.  Anticipation in familial lattice corneal dystrophy type I with R124C mutation in the TGFBI (BIGH3) gene.

Authors:  Pablo Romero; Marlene Vogel; Jose-Manuel Diaz; Maria-Patricia Romero; Luisa Herrera
Journal:  Mol Vis       Date:  2008-05-07       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.